Eleven women with a positive family history previously underwent surgery for breast cancers, and in five cases BRCA1 (n = 4) or BRCA2 (n = 1), pathogenic alterations were detected in the ovary tumor samples. This evidence concerns the gene BRCA2 and female reproductive organ cancer.